Pulmonx (LUNG)
(Real Time Quote from BATS)
$1.59 USD
+0.04 (2.58%)
Updated Sep 18, 2025 01:52 PM ET
2-Buy of 5 2
F Value B Growth D Momentum D VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
LUNG 1.59 +0.04(2.58%)
Will LUNG be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for LUNG based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for LUNG
What Makes Pulmonx (LUNG) a New Buy Stock
After Plunging 37.5% in 4 Weeks, Here's Why the Trend Might Reverse for Pulmonx (LUNG)
LUNG: What are Zacks experts saying now?
Zacks Private Portfolio Services
Pulmonx Corporation (LUNG) Reports Q2 Loss, Beats Revenue Estimates
Pulmonx Corporation (LUNG) Reports Q1 Loss, Tops Revenue Estimates
P3 Health Partners (PIII) Stock Jumps 8.9%: Will It Continue to Soar?
Other News for LUNG
Is LUNG getting ready to pop? Bollinger Band Squeeze shows up after dropping 1.9%
LUNG forms NR7 on September 16
LUNG Fell Below 20 Day Moving Average on September 15
FMR LLC Reduces Stake in Pulmonx Corp: A Strategic Reassessment?
Is LUNG preparing to trend higher? Crossed Above 20 Day Moving Average shows up after advancing 4.97%